S282: A RANDOMIZED CONTROLLED CLINICAL TRIAL DEMONSTRATES THAT PLASMA FROM CONVALESCENT AND VACCINATED DONORS IMPROVES OUTCOME OF COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISEASE, CANCER OR IMMUNOSUPPRESSION. (23rd June 2022)

• Record Type: Journal Article
• Authors: Müller-Tidow, C.; Janssen, M.; Schäkel, U.; Gall, J.; Leo, A.; Stelmach, P.; Krisam, J.; Baumann, L.; Stermann, J.; Merle, U.; Zeier, M.; Weigand, M. A.; Bullinger, L.; Schrezenmeier, J.-F.; Bornhäuser, M.; Alakel, N.; Witzke, O.; Wolf, T.; Vehreschild, M. J.; Schmiedel, S.; Addo, M. M.; Herth, F.; Kreutner, M; Tepasse, P.-R.; Hertenstein, B.; Hänel, M.; Morgner, A.; Kiehl, M.; Hopfer, O.; Wattad, M.-A.; Schimanski, C. C.; Celik, C; Pohle, T.; Ruhe, M.; Kern, W. V.; Schmitt, A; Schmitt, M.; Dreger, P.; Lorenz, H.-M.; Souto-Carneiro, M.; Halama, N.; Meuer, S.; Kräusslich, H.-G.; Müller, B.; Bartenschlager, R.; Klemmer, J.; Kriegsmann, K.; Schlenk, R. F.; Denkinger, C. M.;
• Is Part Of: HemaSphere. Volume 6(2022)Supplement 3
• Page Start: 183
• Page End: 184
• Publication Date: 2022-06-23
• Subjects: Hematology -- Periodicals; 616.15005
• DOI: 10.1097/01.HS9.0000844020.02619.0f
• Languages: English
• ISSNs: 2572-9241